ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending

July 12, 2013

In Brief: Ames Test Pinpoint Pickles, Cigarettes; AACR Majority Supports Cancer Congress

February 3, 1978

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

In Brief: AACR Grants Record Number Of Awards To Young Investigators; Kersey Leads ASBMT

April 24, 1998

NCI Staff Phone Numbers Listed

September 14, 1979